Very good chance they will get Vitiligo approved as another indication, valuation is ridiculously low if you start to price that in. Jefferies, out of all the analysts, did just that and came up with a PT ~$50.
All IMO DYOR
Disc Medicine - Best comparison stock to Clinuvel, page-18
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.17 |
Change
-0.080(0.52%) |
Mkt cap ! $760.0M | |||
| Open | High | Low | Value | Volume |
| $15.38 | $15.56 | $15.02 | $774.6K | 50.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8378 | $15.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.26 | 808 | 2 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |